Integrative metagenomic and metabolomic analyses reveal gut microbiota-derived multiple hits connected to development of gestational diabetes mellitus in humans

References

• Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care. 2007;30(2):S141–17. doi:10.2337/dc07-s206.
   PubMed Web of Science ®Google Scholar
• Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–1868. doi:10.2337/diacare.25.10.1862.
   PubMed Web of Science ®Google Scholar
• Nicklas JM, Miller LJ, Zera CA, Davis RB, Levkoff SE, Seely EW. Factors associated with depressive symptoms in the early postpartum period among women with recent gestational diabetes mellitus. Matern Child Health J. 2013;17(9):1665–1672. doi:10.1007/s10995-012-1180-y.
   PubMed Web of Science ®Google Scholar
• Reece EA, Leguizamon G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet. 2009;373(9677):1789–1797. doi:10.1016/S0140-6736(09)60515-8.
   PubMed Web of Science ®Google Scholar
• McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. doi:10.1038/s41572-019-0098-8.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71. doi:10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15(5):261–273. doi:10.1038/s41574-019-0156-z.
   PubMed Web of Science ®Google Scholar
• Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Manneras-Holm L, Ståhlman M, Olsson LM, Serino M, Planas-Fèlix M, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23(7):850–858. doi:10.1038/nm.4345.
   PubMed Web of Science ®Google Scholar
• Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet Med. 2004;21(2):103–113. doi:10.1046/j.1464-5491.2003.00985.x.
   PubMed Web of Science ®Google Scholar
• Ferrocino I, Ponzo V, Gambino R, Zarovska A, Leone F, Monzeglio C, Goitre I, Rosato R, Romano A, Grassi G, et al. Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (GDM). Sci Rep. 2018;8(1):12216. doi:10.1038/s41598-018-30735-9.
   PubMedGoogle Scholar
• Kuang YS, Lu JH, Li SH, Li JH, Yuan MY, He JR, Chen -N-N, Xiao W-Q, Shen S-Y, Qiu L, et al. Connections between the human gut microbiome and gestational diabetes mellitus. Gigascience. 2017;6(8):1–12. doi:10.1093/gigascience/gix058.
   Web of Science ®Google Scholar
• Wang J, Zheng J, Shi W, Du N, Xu X, Zhang Y, Ji P, Zhang F, Jia Z, Wang Y, et al. Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus. Gut. 2018;67(9):1614–1625. doi:10.1136/gutjnl-2018-315988.
   PubMed Web of Science ®Google Scholar
• Krautkramer KA, Fan J, Backhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77–94. doi:10.1038/s41579-020-0438-4.
   PubMed Web of Science ®Google Scholar
• Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, Forslund K, Hildebrand F, Prifti E, Falony G, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535(7612):376–381. doi:10.1038/nature18646.
   PubMed Web of Science ®Google Scholar
• Pedersen HK, Forslund SK, Gudmundsdottir V, Petersen AO, Hildebrand F, Hyotylainen T, Nielsen T, Hansen T, Bork P, Ehrlich SD, et al. A computational framework to integrate high-throughput ‘-omics’ datasets for the identification of potential mechanistic links. Nat Protoc. 2018;13(12):2781–2800. doi:10.1038/s41596-018-0064-z.
   PubMed Web of Science ®Google Scholar
• Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041.
   PubMed Web of Science ®Google Scholar
• Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee YS, De Vadder F, Arora T, Hallen A, Martens E, Björck I, Bäckhed F, et al. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of prevotella. Cell Metab. 2015;22(6):971–982. doi:10.1016/j.cmet.2015.10.001.
   PubMed Web of Science ®Google Scholar
• Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2017;19(1):29–41. doi:10.1111/1462-2920.13589.
   PubMed Web of Science ®Google Scholar
• Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The genus alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front Immunol. 2020;11:906. doi:10.3389/fimmu.2020.00906.
   PubMed Web of Science ®Google Scholar
• Henke MT, Kenny DJ, Cassilly CD, Vlamakis H, Xavier RJ, Clardy J. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci U S A. 2019;116(26):12672–12677. doi:10.1073/pnas.1904099116.
   PubMed Web of Science ®Google Scholar
• Nagao-Kitamoto H, Kamada N. Host-microbial cross-talk in inflammatory bowel disease. Immune Netw. 2017;17(1):1–12. doi:10.4110/in.2017.17.1.1.
   PubMed Web of Science ®Google Scholar
• Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC, Lai H-C. Next generation probiotics in disease amelioration. J Food Drug Anal. 2019;27(3):615–622. doi:10.1016/j.jfda.2018.12.011.
   PubMed Web of Science ®Google Scholar
• Oba S, Sunagawa T, Tanihiro R, Awashima K, Sugiyama H, Odani T, Nakamura Y, Kondo A, Sasaki D, Sasaki K, et al. Prebiotic effects of yeast mannan, which selectively promotes Bacteroides thetaiotaomicron and Bacteroides ovatus in a human colonic microbiota model. Sci Rep. 2020;10(1):17351. doi:10.1038/s41598-020-74379-0.
   PubMed Web of Science ®Google Scholar
• Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One. 2013;8(8):e71108. doi:10.1371/journal.pone.0071108.
   PubMed Web of Science ®Google Scholar
• Sun T, Meng F, Zhao H, Yang M, Zhang R, Yu Z, Huang X, Ding H, Liu J, Zang S, et al. Elevated first-trimester neutrophil count is closely associated with the development of maternal gestational diabetes mellitus and adverse pregnancy outcomes. Diabetes. 2020;69(7):1401–1410. doi:10.2337/db19-0976.
   PubMed Web of Science ®Google Scholar
• Ogunnowo-Bada EO, Heeley N, Brochard L, Evans ML. Brain glucose sensing, glucokinase and neural control of metabolism and islet function. Diabetes Obes Metab. 2014;16(S1):26–32. doi:10.1111/dom.12334.
   PubMedGoogle Scholar
• Wang GJ, Volkow ND, Fowler JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets. 2002;6(5):601–609. doi:10.1517/14728222.6.5.601.
   PubMedGoogle Scholar
• Ter Horst KW, Lammers NM, Trinko R, Opland DM, Figee M, Ackermans MT, Booij J, Den Munckhof PV, Schuurman PR, Fliers E, et al. Striatal dopamine regulates systemic glucose metabolism in humans and mice. Sci Transl Med. 2018;10(442):eaar3752. doi:10.1126/scitranslmed.aar3752.
   PubMed Web of Science ®Google Scholar
• Bahler L, Verberne HJ, Brakema E, Tepaske R, Booij J, Hoekstra JB, Holleman F. Bromocriptine and insulin sensitivity in lean and obese subjects. Endocr Connect. 2016;5(6):44–52. doi:10.1530/EC-16-0051.
   PubMed Web of Science ®Google Scholar
• Ben-Jonathan N, Munsick RA. Dopamine and prolactin in human pregnancy. J Clin Endocrinol Metab. 1980;51(5):1019–1025. doi:10.1210/jcem-51-5-1019.
   PubMed Web of Science ®Google Scholar
• Ben-Jonathan N, Hugo ER, Brandebourg TD, LaPensee CR. Focus on prolactin as a metabolic hormone. Trends Endocrinol Metab. 2006;17(3):110–116. doi:10.1016/j.tem.2006.02.005.
   PubMed Web of Science ®Google Scholar
• Terra LF, Garay-Malpartida MH, Wailemann RA, Sogayar MC, Labriola L. Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways. Diabetologia. 2011;54(6):1388–1397. doi:10.1007/s00125-011-2102-z.
   PubMed Web of Science ®Google Scholar
• Arumugam R, Horowitz E, Lu D, Collier JJ, Ronnebaum S, Fleenor D, Freemark M. The interplay of prolactin and the glucocorticoids in the regulation of beta-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: implications for carbohydrate metabolism in pregnancy. Endocrinology. 2008;149(11):5401–5414. doi:10.1210/en.2008-0051.
   PubMed Web of Science ®Google Scholar
• Moldrup A, Petersen ED, Nielsen JH. Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. Endocrinology. 1993;133(3):1165–1172. doi:10.1210/endo.133.3.8365359.
   PubMed Web of Science ®Google Scholar
• Huang C, Snider F, Cross JC. Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology. 2009;150(4):1618–1626. doi:10.1210/en.2008-1003.
   PubMed Web of Science ®Google Scholar
• Miller TL, Wolin MJ. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol. 1996;62(5):1589–1592. doi:10.1128/aem.62.5.1589-1592.1996.
   PubMed Web of Science ®Google Scholar
• Zietek M, Celewicz Z, Szczuko M, Su C, Ouyang Y, Huang F, Jia X, Li L, Bai J, Zhang B. Short-chain fatty acids, maternal microbiota and metabolism in pregnancy. Nutrients. 2021;14(1):13. doi:10.3390/nu14010013.
   PubMedGoogle Scholar
• Roy R, Nguyen-Ngo C, Lappas M. Short-chain fatty acids as novel therapeutics for gestational diabetes. J Mol Endocrinol. 2020;65(2):21–34. doi:10.1530/JME-20-0094.
   PubMed Web of Science ®Google Scholar
• Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141–150. doi:10.1016/j.diabres.2014.04.006.
   PubMed Web of Science ®Google Scholar
• Moraes-Vieira PM, Yore MM, Sontheimer-Phelps A, Castoldi A, Norseen J, Aryal P, Simonyté Sjödin K, Kahn BB. Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4. Proc Natl Acad Sci U S A. 2020;117(49):31309–31318. doi:10.1073/pnas.2013877117.
   PubMed Web of Science ®Google Scholar
• Jimenez-Gomez Y, Mattison JA, Pearson KJ, Martin-Montalvo A, Palacios HH, Sossong AM, Ward T, Younts C, Lewis K, Allard J, et al. Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab. 2013;18(4):533–545. doi:10.1016/j.cmet.2013.09.004.
   PubMed Web of Science ®Google Scholar
• Volpe L, Di Cianni G, Lencioni C, Cuccuru I, Benzi L, Del Prato S. Gestational diabetes, inflammation, and late vascular disease. J Endocrinol Invest. 2007;30(10):873–879. doi:10.1007/BF03349231.
   PubMed Web of Science ®Google Scholar
• Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20(1):40–54. doi:10.1038/s41577-019-0198-4.
   PubMed Web of Science ®Google Scholar
• Deschasaux M, Bouter KE, Prodan A, Levin E, Groen AK, Herrema H, Tremaroli V, Bakker GJ, Attaye I, Pinto-Sietsma S-J, et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med. 2018;24(10):1526–1531. doi:10.1038/s41591-018-0160-1.
   PubMed Web of Science ®Google Scholar
• International Association of D, Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano, PA, Damn P, Dyer AR, Leiva AD, Hod M, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33: 676–682. doi:10.2337/dc09-1848.
   PubMed Web of Science ®Google Scholar
• Panneerselvam J, Xie G, Che R, Su M, Zhang J, Jia W, Fei P. Distinct metabolic signature of human bladder cancer cells carrying an impaired Fanconi anemia tumor-suppressor signaling pathway. J Proteome Res. 2016;15(4):1333–1341. doi:10.1021/acs.jproteome.6b00076.
   PubMed Web of Science ®Google Scholar
• Li J, Sung CY, Lee N, Ni Y, Pihlajamaki J, Panagiotou G, El-Nezami H. Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci U S A. 2016;113(9):E1306–15. doi:10.1073/pnas.1518189113.
   PubMed Web of Science ®Google Scholar
• Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, Tett A, Huttenhower C, Segata N. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015;12(10):902–903. doi:10.1038/nmeth.3589.
   PubMed Web of Science ®Google Scholar
• Iadanza E, Fabbri R, Bašić-čičak D, Amedei A, Telalovic JH. Gut microbiota and artificial intelligence approaches: a scoping review. Health and Technology. 2020;10(6):1343–1358. doi:10.1007/s12553-020-00486-7.
   Web of Science ®Google Scholar
• Rodriguez-Perez R, Bajorath J. Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions. J Comput Aided Mol Des. 2020;34(10):1013–1026. doi:10.1007/s10822-020-00314-0.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457–62. doi:10.1093/nar/gkv1070.
   PubMed Web of Science ®Google Scholar